Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ifosfamide and doxorubicin in localized non-rhabdomyosarcoma soft tissue sarcomas
NCT00334854Phase 3Unknown
- Sponsor
- European Paediatric Soft Tissue Sarcoma Study Group
- Start
- Mar 2006
- Primary completion
- May 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 9
01
Overview
Phase 3, open-label trial of ifosfamide and doxorubicin in synovial sarcoma (SS) and soft tissue sarcoma (STS), sponsored by European Paediatric Soft Tissue Sarcoma Study Group. Status: unknown.
02
Drugs
ifosfamidedoxorubicin
03
Conditions
synovial sarcoma (SS)soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00334854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334854.